Cetuximab reversal of resistance to chronomodulated chemotherapy in heavily-pretreated patients with metastatic colorectal cancer (MCC) without amplification of epidermal growth factor receptor (EGFR) gene

Francis Lévi,Abdoulaye Karaboué,M.P. Bralet,Pasquale F. Innominato,M. O. Herelle,Sylvie Giacchetti,René Adam,C. Jasmin,Catherine Guettier,Mohamed Bouchahda

Cetuximab reversal of resistance to chronomodulated chemotherapy in heavily-pretreated patients with metastatic colorectal cancer (MCC) without amplification of epidermal growth factor receptor (EGFR) gene

2006

Francis Lévi
Abdoulaye Karaboué
M.P. Bralet
Pasquale F. Innominato
M. O. Herelle
Sylvie Giacchetti
René Adam
C. Jasmin
Catherine Guettier
Mohamed Bouchahda

13104 Background Skin toxicity and EGFR amplification reportedly predicted for Cetux-reversal of MCC resistance to standard chemotherapy. We explored these relations for Cetux reversal of resistanc...

Keywords:

Cetuximab
Cancer research
Gene
Colorectal cancer
Epidermal growth factor receptor
Chemotherapy
Medicine
Internal medicine
EGFR Amplification
Oncology
Skin toxicity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations